We focus on the development of drug candidates to the second phase of clinical studies. The main research and development direction is anti-fibrotic small molecule drugs, while advancing the development of diabetic, hyperlipidemia and renal anemia drugs.
15860728237 Ms. Liang
4th floor, building A19, Xiamen biomedical industrial park, No. 2036, Haicang District, Xiamen City, Fujian Province